Welcome, visitor! [ Register | Loginrss  |  tw
 

$10,000.00--Negotiable & Agents Welcomed

Cell Queue® Pharmaceuticals

  • Registration Number: 5041900
  • Registered in: US
  • Int. Class: 005
  • Usage Status: In Use

Description

Cell Queue (R) Pharmaceuticals may someday become a preeminent leader in developing through its unique patented cell technologies new forms of antibiotics to combat the growing list of antimicrobial-resistant bacteria crucial to fighting life-threatening infections.This company will become a future major biotech’s valued subsidiary. You can count on that.
The word “Queue” in this mark refers to the actual orderly sequential chemical process/reaction in the “AT Queue” biochemical model that accounts for chromosomal banding in the DNA of the respective bacterium.In this chemical queuing process,research biochemists can change the site where the antibiotic normally works or choose the site where the bacteria can mutate or transfer its genetic material.
10% sales commission given to qualified agents or brokers who bring me a buyer.In the interim before my eventual sale, I have become a wholesale distributor of Hydrogen Peroxide. H2O2 among other uses, is a proven remedy for Bacterial Vaginosis with an 89% cure rate.
Some new pharma brand logos with no previous revenue streams have sold for as much as $75 million based on their future “goodwill value.”(Source:spokesperson for DevicePharm,Irvine, California).
My marketing efforts may take some time; literally years, for major biotech firms to mull over and fully comprehend this much-valued future logo. Someday Cell Queue(R) Pharmaceuticals will be as ubiquitous to the microbial world as Elvis and O.J. are to Las Vegas. Rest assured, my efforts will eventually make it so.I forgot to mention these important facts–the domain www.cellqueuepharmaceuticals.com and cellqueue.com are both included in the current purchase price. Will also consider licensing the mark with negotiable terms available.This trademark might also fit nicely into a nutraceutical CEO’s plan to expand his company’s branding power and breadth as tumeric with its anti-inflammatory properties also fights bad bacteria.As an intangible asset, this mark could very well be worth over twenty times the price I have listed on this exchange, providing it is the right fit.6-24-19: Today I just learned from livescience.com that CBD oil (which is legal in all fifty states) shows remarkable progress “in vitro” in treating gram-positive bad bacteria such as staph and strep. This might also fit under the “cell queue umbrella” upon future renewal with the USPTO three years from now.

Share this

You must be logged in to inquire about this trademark.